Mathematically modeling the sequential application of a cytotoxic nanoparticle and a PI3K-inhibitor enhances anti-tumor efficacy

نویسندگان

  • Ambarish Pandey
  • Ashish Kulkarni
  • Bhaskar Roy
  • Aaron Goldman
  • Sasmit Sarangi
  • Poulomi Sengupta
  • Colin Phipps
  • Jawahar Kopparam
  • Michael Oh
  • Sudipta Basu
  • Mohammad Kohandel
  • Shiladitya Sengupta
چکیده

Ambarish Pandey , Ashish Kulkarni, Bhaskar Roy, Aaron Goldman, Sasmit Sarangi, Poulomi Sengupta, Colin Phipps, Jawahar Kopparam, Michael Oh, Sudipta Basu, Mohammad Kohandel, Shiladitya Sengupta. Laboratory for Nanomedicine, Division of Biomedical Engineering, Brigham and Women’s Hospital, Department of Medicine, Harvard Medical School. Department of Applied Mathematics, University of Waterloo, Waterloo, ON, N2L 3G1, Canada. Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, ON, N2L 3G1, Canada. Center for Mathematical Medicine, Fields Institute for Research in Mathematical Sciences, Toronto, ON, M5T 3J1, Canada. Current Affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy.

Nanomedicines that preferentially deploy cytotoxic agents to tumors and molecular targeted therapeutics that inhibit specific aberrant oncogenic drivers are emerging as the new paradigm for the management of cancer. While combination therapies are a mainstay of cancer chemotherapy, few studies have addressed the combination of nanomedicines and molecular targeted therapeutics. Furthermore, limi...

متن کامل

PI3K and mTOR inhibitor, NVP-BEZ235, is more toxic than X-rays in prostate cancer cells

Background: Radiotherapy and adjuvant androgen deprivation therapy have historically been the first treatment choices for prostate cancer but treatment resistance often limits the capacity to effectively manage the disease. Therefore, alternative therapeutic approaches are needed. Here, the efficacies of radiotherapy and targeting the pro-survival cell signaling components epidermal growth fact...

متن کامل

Integrated Systems and Technologies: Mathematical Oncology Sequential Applicationof aCytotoxicNanoparticle andaPI3K Inhibitor Enhances Antitumor Efficacy

Nanomedicines that preferentially deploy cytotoxic agents to tumors andmolecular targeted therapeutics that inhibit specific aberrant oncogenic drivers are emerging as the new paradigm for the management of cancer. While combination therapies are a mainstay of cancer chemotherapy, few studies have addressed the combination of nanomedicines and molecular targeted therapeutics. Furthermore, limit...

متن کامل

تاثیر سینرژیسم داروی GS-1101 با دوکسوروبیسین در رده سلولی لوسمی لنفوبلاستیک حاد

Background and purpose: Interest into targeting PI3K in cancer has increased by the recent disclosure that aberrant activity of PI3K/Akt signaling pathway is associated with disease recurrence and poor outcome in different malignancies. The aim of this study was to investigate the potentiating effect of PI3K inhibitor, GS-1101 on doxorubicin-induced cell death in acute lymphoblastic leukemia-de...

متن کامل

The anti-tumor efficacy of nanoparticulate form of ICD-85 versus free form

Biodegradable polymeric nanoparticles (NPs) have been intensively studied as a possible way to enhance anti-tumor efficacy while reducing side effects. ICD-85, derived from the venom of two separate species of venomous animals, has been shown to exhibit anti-cancer activity. In this report polymer based sodium alginate nanoparticles of ICD-85 was used to enhance its therapeutic effects and redu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013